Phenotropil (Phenylpiracetam) by Valenta Pharm is a pharmaceutical-grade nootropic compound formulated as 100 mg oral tablets. Phenylpiracetam is a structural derivative of piracetam, distinguished by the addition of a phenyl group that enhances blood-brain barrier permeability and central nervous system activity relative to the parent compound. It is recognized in neuropsychopharmacological research for its dopaminergic and cholinergic modulatory properties.
 
✔ Key Research Insights
Studied for its enhanced blood-brain barrier penetration relative to piracetam, attributed to the addition of a phenyl group to the base racetam structure in pharmacokinetic research
Investigated for its modulatory effects on dopamine and acetylcholine neurotransmitter pathways, with documented associations with cognitive processing parameters in research subjects
Researched for its influence on concentration, memory recall, and cognitive processing efficiency in neuropsychopharmacological observations
Examined for its effects on motivation indices and mood regulation parameters in documented subject populations
Documented for its rapid onset pharmacokinetic profile, with effects reported within approximately 30–60 minutes of administration and a duration of approximately 4–6 hours in clinical observations
Researched for its effects on cognitive and physical stress tolerance in subject populations facing conditions of elevated intellectual or physical demand
Manufactured by Valenta Pharm under GMP standards with third-party quality testing
 
📦 Product Specifications
Manufacturer: Valenta Pharm
Product: Phenotropil
Molecule: Phenylpiracetam (N-carbamoylmethyl-4-phenyl-2-pyrrolidone)
Concentration: 100 mg per tablet
Form: Oral tablet
Volume: 30 tablets per pack
Clinical reference: dosage should be determined by a qualified healthcare professional. Administration after 16:00 is generally not recommended in clinical usage guidance due to the compound's stimulatory profile.
 
⚙ How It Works
Phenylpiracetam is a racetam-class nootropic compound derived from piracetam through the addition of a phenyl substituent at the 4-position of the pyrrolidone ring. This structural modification is documented in pharmacological literature to significantly enhance lipophilicity, facilitating more efficient passage across the blood-brain barrier in research subjects relative to the parent piracetam molecule. Within the central nervous system, phenylpiracetam has been investigated for its modulatory effects on dopaminergic and cholinergic neurotransmission pathways, mechanisms associated in research literature with cognitive processing, attentional capacity, and motivational regulation. Its comparatively rapid onset of action and multi-hour duration of effect have been documented in neuropsychopharmacological studies examining racetam derivatives. Late-day administration is generally discouraged in clinical usage protocols due to the compound's documented stimulatory properties and potential interference with sleep architecture.
 
⭐ Product Overview
Manufactured by Valenta Pharm under GMP standards with third-party quality verification
Precise 100 mg per tablet concentration supporting consistent and accurate dosing protocols
Phenyl-modified racetam derivative with a documented pharmacological profile distinct from and more potent than classic piracetam in comparative neuropsychopharmacological research
Established nootropic compound with a recognized research history in cognitive and neurological pharmacology literature
Widely referenced in nootropic and neuropsychopharmacological research under the phenylpiracetam and Phenotropil designations